Cyclizine
General information:
| Withdrawn ID: | 1215 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | R06AE03 |
| R06AE53 | |
| Molecular Formula: | C18H22N2 |
| Molweight: | 266.381 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|---|
| First approved: | 1982 |
Side-effects:
| Total reported cases (submitted by medical professionals) with Cyclizine as primary suspect: | 5 |
|---|
Reported final outcomes:
| Hospitalization (initial or prolonged): | 2 |
|---|---|
| Death: | 1 |
| Disability: | 1 |
Reported side-effects:
| Side-effect | Case number |
|---|---|
| Tremor | 1 |
| Similar reaction on previous exposure to drug | 1 |
| Post inflammatory pigmentation change | 1 |
| Pallor | 1 |
| Overdose | 1 |
| NAUSEA | 1 |
| Myoclonus | 1 |
| Myoclonic epilepsy | 1 |
| Loss of consciousness | 1 |
| Linear IgA disease | 1 |
| Intentional overdose | 1 |
| Feeling abnormal | 1 |
| DRUG INTERACTION | 1 |
| Convulsion | 1 |
| Chest discomfort | 1 |
Toxicity information:
| Toxicity class: | 3 |
|---|---|
| Toxicity type: | N/A |
| LD50: | 200 mg/kg |
External links:
| ChEBML: | CHEMBL648 |
|---|---|
| DrugBank: | DB01176 |